UTHR Current Ratio

The Current Ratio of United Therapeutics Corporation (UTHR) is 6.60.

Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.

UTHR Current Ratio - Historical Value

Date	Value
2025-12-31	6.60
2024-12-31	5.25
2023-12-31	4.41
2022-12-31	9.85
2021-12-31	7.61
2020-12-31	6.70
2019-12-31	4.03
2018-12-31	6.39
2017-12-31	3.26
2016-12-31	4.29

UTHR Current Ratio - Peers Comparison

Ticker	Name	Value
FGEN	FibroGen Inc	1.47
ALLO	Allogene Therapeutics, Inc.	7.93
CCXI	Churchill Capital Corp XI	8.13
CRSP	CRISPR Therapeutics AG	13.32
IOVA	Iovance Biotherapeutics Inc	3.20
REGN	Regeneron Pharmaceuticals, Inc.	4.13
SANA	Sana Biotechnology, Inc.	1.89
ALKS	Alkermes Plc	3.55
ARNA	Arena Pharmaceuticals Inc	8.59
MRTX	Mirati Therapeutics Inc	6.96
950160.KQ	Kolon TissueGene Inc	0.24
APLS	Apellis Pharmaceuticals, Inc.	3.14
HALO	Halozyme Therapeutics, Inc.	4.66
MRNA	Moderna, Inc.	3.29
RLAY	Relay Therapeutics, Inc.	22.61
TGTX	TG Therapeutics, Inc.	6.25
TPTX	Turning Point Therapeutics Inc	21.08
ASND	Ascendis Pharma A/S	1.04
BPMC	Blueprint Medicines Corp	2.85
KOD	Kodiak Sciences Inc.	4.72
950200.KQ	Psomagen Inc	1.67
950220.KQ	Neoimmunetech Inc	3.08
LEGN	Legend Biotech Corporation	1.96
VRTX	Vertex Pharmaceuticals Incorporated	2.90
XLRN	Acceleron Pharma Inc	14.84
SRPT	Sarepta Therapeutics, Inc.	2.32
ABBV	AbbVie Inc.	0.67
EBS	Emergent BioSolutions Inc.	5.01
FATE	Fate Therapeutics Inc	5.79
FOLD	Amicus Therapeutics Inc	2.84
IONS	Ionis Pharmaceuticals, Inc.	3.83
LGND	Ligand Pharmaceuticals Incorporated	22.23
RVMD	Revolution Medicines, Inc.	7.14
AMGN	Amgen Inc	1.14
BHVN	Biohaven Ltd.	3.18
GILD	Gilead Sciences, Inc.	1.55
NTLA	Intellia Therapeutics, Inc.	5.08